Industry Commitment For Antibiotic Resistance Strategy

by | Apr 8, 2014 | News | 0 comments

In an update to the public last week, the FDA announced that all but one animal drug company have committed to seek withdrawal of approvals for any production uses of affected drug applications and change the remaining therapeutic uses of their products from over-the-counter to use by Veterinary Feed Directive or prescription. These changes stem from the implementation of FDA Guidance #213 that was announced in December of last year. The FDA is pleased with the strong responses received thus far and promises to continue to provide updates to the public. For the official announcement from the FDA, read here.

Recent GVL Blog Posts

GVL SAHO Appreciation: Updates to NVAP Accreditation and ADT Reporting

GVL SAHO Appreciation: Updates to NVAP Accreditation and ADT Reporting

October is State Animal Health Official (SAHO) appreciation month at GVL. Listen as our product manager, Stacey Noe, describes the updates we've made to our software platform to help SAHOs do their job more efficiently. Don't forget to explore our SAHO resource page,...

Riverside Animal Hospital, GVL Customer of the Month

Riverside Animal Hospital, GVL Customer of the Month

Pictured above: back - Donna, Dr. Portnoy, Krista, Lisa, Emily, Jen, Dr. Watson, Dr. Gilmore; front - Nicole and Teddy Toodles, Amy, Megan, Francesca.Every month, we are featuring veterinary clinics and hospitals who utilize GVL in their practices. We look forward to...